Raymond James downgraded Ginkgo Bioworks to Market Perform from Outperform with a price target of $2.50, down from $3.50.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DNA:
- Cathie Wood’s ARK Investment bought 515K shares of Ginkgo Bioworks today
- Tesla initiated, Kellanova upgraded: Wall Street’s top analyst calls
- Ginkgo Bioworks price target lowered to $7 from $12 at TD Cowen
- Ginkgo Bioworks, Foremost Farms announce partnership
- Ginkgo Bioworks downgraded to Neutral from Buy at BTIG